Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids

Background: Cannabis use is common among individuals with pain who are prescribed opioids, occurring in approximately 10% of this population. This study aims to explore the relationship between non-medical cannabis use and other health risks among individuals filling opioids at community pharmacies....

Full description

Saved in:
Bibliographic Details
Main Authors: M. Aryana Bryan (Author), Elizabeth Charron (Author), Omolola Adeoye-Olatunde (Author), Jennifer Brown (Author), Udi Ghitza (Author), T. John Winhusen (Author), Gerald Cochran (Author)
Format: Book
Published: MDPI AG, 2021-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_06aee2c962244d3f8b960b0a0e7bafba
042 |a dc 
100 1 0 |a M. Aryana Bryan  |e author 
700 1 0 |a Elizabeth Charron  |e author 
700 1 0 |a Omolola Adeoye-Olatunde  |e author 
700 1 0 |a Jennifer Brown  |e author 
700 1 0 |a Udi Ghitza  |e author 
700 1 0 |a T. John Winhusen  |e author 
700 1 0 |a Gerald Cochran  |e author 
245 0 0 |a Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids 
260 |b MDPI AG,   |c 2021-08-01T00:00:00Z. 
500 |a 10.3390/pharmacy9030134 
500 |a 2226-4787 
520 |a Background: Cannabis use is common among individuals with pain who are prescribed opioids, occurring in approximately 10% of this population. This study aims to explore the relationship between non-medical cannabis use and other health risks among individuals filling opioids at community pharmacies. Methods: This study was an exploratory secondary data analysis of a National Drug Abuse Treatment Clinical Trials Network (CTN)-sponsored study, Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening, examining the relationship between risky cannabis use and depressive symptoms, pain, overdose, and other substance misuse among individuals filling opioid prescriptions in community pharmacies (N = 1440). Results: Participants reporting moderate- to high-risk compared to low-risk cannabis use were more likely to report depressive symptoms (adjusted OR = 1.67, 95% CI = 1.11-2.56), history of overdose (adjusted OR = 2.15, 95% CI = 1.34-3.44), and moderate- to high-risk use of alcohol (adjusted OR = 2.10, 95% CI = 1.28-3.45), opioids (adjusted OR = 2.50, 95% CI = 1.67-3.76), sedatives (adjusted OR = 2.58, 95% CI = 1.72-3.86), stimulants (adjusted OR = 4.79, 95% CI = 2.83-8.01), and tobacco (adjusted OR = 3.60, 95% CI = 2.47-5.24). Conclusions: Community pharmacies may be valuable sites for identifying, studying, and intervening with substance use problems. 
546 |a EN 
690 |a cannabis 
690 |a community pharmacy 
690 |a opioids 
690 |a substance use 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmacy, Vol 9, Iss 3, p 134 (2021) 
787 0 |n https://www.mdpi.com/2226-4787/9/3/134 
787 0 |n https://doaj.org/toc/2226-4787 
856 4 1 |u https://doaj.org/article/06aee2c962244d3f8b960b0a0e7bafba  |z Connect to this object online.